Brokers Issue Forecasts for TriMas’ Q1 Earnings (NASDAQ:TRS)

TriMas Co. (NASDAQ:TRS) – Analysts at Zacks Research reduced their Q1 2025 earnings per share estimates for shares of TriMas in a report released on Monday, March 10th. Zacks Research analyst M. Das now anticipates that the industrial products company will earn $0.43 per share for the quarter, down from their previous estimate of $0.44. The consensus estimate for TriMas’ current full-year earnings is $1.69 per share. Zacks Research also issued estimates for TriMas’ Q1 2026 earnings at $0.47 EPS and FY2027 earnings at $2.18 EPS.

Several other research firms have also commented on TRS. StockNews.com upgraded shares of TriMas from a “sell” rating to a “hold” rating in a research report on Wednesday, November 13th. BWS Financial restated a “buy” rating and issued a $40.00 target price on shares of TriMas in a research report on Friday, February 28th.

TriMas Price Performance

Shares of NASDAQ TRS opened at $24.46 on Wednesday. The company has a debt-to-equity ratio of 0.60, a current ratio of 2.83 and a quick ratio of 1.44. The firm has a market capitalization of $992.66 million, a PE ratio of 38.22 and a beta of 0.65. TriMas has a 1-year low of $19.33 and a 1-year high of $28.51. The business’s fifty day moving average price is $23.56 and its two-hundred day moving average price is $25.06.

TriMas Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, March 7th. Shareholders of record on Friday, February 28th were given a dividend of $0.04 per share. The ex-dividend date of this dividend was Friday, February 28th. This represents a $0.16 dividend on an annualized basis and a yield of 0.65%. TriMas’s dividend payout ratio (DPR) is presently 27.12%.

Insiders Place Their Bets

In related news, Director Jeffrey A. Fielkow purchased 2,500 shares of TriMas stock in a transaction dated Friday, February 28th. The stock was bought at an average cost of $20.78 per share, with a total value of $51,950.00. Following the purchase, the director now owns 11,013 shares in the company, valued at approximately $228,850.14. The trade was a 29.37 % increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Shawn Sedaghat acquired 554,149 shares of the firm’s stock in a transaction dated Monday, March 10th. The stock was bought at an average price of $24.07 per share, with a total value of $13,338,366.43. Following the completion of the acquisition, the director now directly owns 900,974 shares of the company’s stock, valued at approximately $21,686,444.18. This represents a 159.78 % increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last quarter, insiders acquired 806,246 shares of company stock worth $19,338,213. 1.10% of the stock is owned by company insiders.

Institutional Trading of TriMas

Institutional investors have recently modified their holdings of the company. Bank of America Corp DE raised its position in TriMas by 127.3% in the fourth quarter. Bank of America Corp DE now owns 3,513,638 shares of the industrial products company’s stock worth $86,400,000 after acquiring an additional 1,967,738 shares in the last quarter. Bellecapital International Ltd. acquired a new position in shares of TriMas in the 4th quarter worth approximately $29,160,000. Impax Asset Management Group plc raised its holdings in shares of TriMas by 216.4% in the 3rd quarter. Impax Asset Management Group plc now owns 410,000 shares of the industrial products company’s stock worth $10,467,000 after purchasing an additional 280,431 shares in the last quarter. Raymond James Financial Inc. acquired a new stake in TriMas during the fourth quarter valued at approximately $6,698,000. Finally, Wellington Management Group LLP boosted its holdings in TriMas by 10.7% during the third quarter. Wellington Management Group LLP now owns 2,619,359 shares of the industrial products company’s stock worth $66,872,000 after buying an additional 252,537 shares in the last quarter. Institutional investors and hedge funds own 99.42% of the company’s stock.

About TriMas

TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.